Art Technology Acquisition Corp. ARTC
10.01 USD -0.02 (-0.20%)
At closeNov 9, 2026, 4:00 PM EST
10.00 -0.01 -0.10%
After hours · Nov 9, 4:00 PM ET
10.01 Day range 10.01
9.79 52-week range 10.05
- YTD
- +1.83%
- 1 year
- +1.83%
News
benzinga.com ArthroCare Q1 Earnings Miss Ests; Revs In Line - Analyst Blog
benzinga.com ArthroCare Corporation Reports Q1 EPS of $0.32 vs $0.36 Est; Revenue of $96.10M vs $95.80M Est
benzinga.com MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
benzinga.com MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
benzinga.com Varian Medical Systems Settles Patent Dispute - Analyst Blog
benzinga.com Thoratec Slapped with Class I Recall for HeartMate Controller - Analyst Blog
benzinga.com Balanced View on Cyberonics - Analyst Blog
benzinga.com ArthroCare Corporation Reports Q4 EPS of $0.30 vs $0.39 Est; Revenue of $101.70M vs $100.65M Est
benzinga.com Benzinga's M&A Chatter for Monday February 3, 2014
benzinga.com Market Wrap For February 3: Bears In Complete and Absolute Control
benzinga.com Mid-Afternoon Market Update: Markets Continue to Decline on Disappointing ISM Number Among Other Factors
benzinga.com Mid-Day Market Update: Dow Tumbles 250 Points; Ford Shares Slip On Weak Sales Report
benzinga.com Mid-Morning Market Update: Markets Drop; Smith & Nephew To Acquire ArthroCare For $48.25/Share
benzinga.com Benzinga's Top #PreMarket Gainers
benzinga.com US Stock Futures Flat Ahead Of Economic Data
benzinga.com Smith & Nephew To Acquire ArthroCare For $1.7B
benzinga.com Benzinga's Volume Movers
benzinga.com ArthroCare Corporation Reports Q2 EPS of $(0.27) Which May Not Compare $0.34 Est; Revenue of $92.10M Which May Not Compare $93.67M Est
benzinga.com ArthroCare Buys ENTrigue Surgical for $45M in Cash
benzinga.com ArthroCare Announces Acquisition of ENTrigue Surgical, Inc.
benzinga.com ArthroCare Corporation Reports Q4 EPS of $0.30 vs $0.36 Est; Revenue of $96.60M vs $93.78M Est
benzinga.com Arthrocare Reports Q2 EPS $0.34 vs $0.37 Est; Revenues $91.7M vs $93.18M Est
benzinga.com Arthrocare Reports Q1 EPS $0.36 vs $0.34 Est; Revenues $92.9M vs $88.21M Est
benzinga.com ArthroCare Down 18% After Missing Earnings Estimates
benzinga.com UPDATE: Jefferies Downgrades ArthroCare to Hold
benzinga.com Canaccord Maintains Buy Rating and $43.50 PT on Arthocare
benzinga.com ArthroCare Announces Agreement in Principle to Settle Securities Class Action
benzinga.com UPDATE: Jefferies Lowers PT to $32 on ArthroCare
benzinga.com Earnings Preview: Stryker's EPS, Revenue Expected to Rise
benzinga.com ArthroCare Receives FDA Clearance for SpeedLock Knotless Fixation Device
benzinga.com NeuroTherm Acquires ArthroCare's Parallax and Contour Product Lines
benzinga.com ArthroCare Receives FDA Clearance for Spartan 6.5 Needled Suture Implant
benzinga.com ArthroCare Receives FDA Clearance for Parallax Contour-enhanced Vertebral Augmentation Device
benzinga.com Jefferies Raises Price Target On ArthroCare (NASDAQ: ARTC)
benzinga.com Benzinga's Volume Movers (KVHI, REGN, ARTC, AAWW)
benzinga.com ArthroCare Reports Q4 EPS of $0.30
benzinga.com ArthroCare Announces Fourth Quarter and Full Year 2010 Financial Results Feb. 14
benzinga.com Benzinga's Volume Movers (WFMI, IPGP, ARTC, DIOD)
benzinga.com Benzinga's Volume Movers (ARTC, KSWS, SMSI, ROSE)
benzinga.com ArthroCare Receives FDA Clearance for SpeedFix
benzinga.com ArthroCare Reports Third Quarter EPS of $.25
benzinga.com A Peek Into The Market Before The Trading Starts
benzinga.com ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
benzinga.com FDA Clears ArthroCare Device - Analyst Blog
benzinga.com ArthroCare Receives FDA Clearance for Parallax Contour Vertebral (ARTC)
benzinga.com ArthroCare to Present at UBS Global Life Sciences Conference
benzinga.com ArthroCare Cuts Costs, Buy Rating Maintained
benzinga.com Arthrocare Tops Estimates By 3c
benzinga.com Benzinga’s Volume Movers (EVVV, PANL, QCOR, ARTC)
benzinga.com Movers And Shakers For March 16 (ATHN, ARTC, AVII, BNHN, CLF, HOG, MGM, BPOP, SONC, CLUB)
